sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
ROIV
Updated 10/6/2026, 10:27 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences Ltd. | Sale | $640,861 | Epperly Melissa B, Director | 17,750 sh | at $36.10 | Filed Oct 5, 6:05 PM ET | Filing | |
| ROIV Roivant Sciences Ltd. | Sale | $7,324,000 | Venker Eric President & Immunovant CEO | 200,000 sh | at $36.62 | Filed Oct 2, 5:37 PM ET | Filing | |
| ROIV Roivant Sciences Ltd. | Sale | $196,230 | Epperly Melissa B, Director | 4,938 sh | at $39.74 | Filed Sep 17, 6:43 PM ET | Filing | |
| ROIV Roivant Sciences Ltd. | Sale | $203,152 | Fitzgerald Meghan Director | 5,112 sh | at $39.74 | Filed Sep 17, 6:42 PM ET | Filing | |
| ROIV Roivant Sciences Ltd. | Sale | $798,000 | Fitzgerald Meghan Director | 20,000 sh | at $39.90 | Filed Sep 10, 9:00 PM ET | Filing | |
| ROIV Roivant Sciences Ltd. | Sale | $7,153,393 | Venker Eric President & Immunovant CEO | 200,000 sh | at $35.77 | Filed Sep 1, 9:00 PM ET | Filing | |
| ROIV Roivant Sciences Ltd. | Sale | $12,360,813 | Sukhatme Mayukh President & CIO, Director | 335,174 sh | at $36.88 | Filed Aug 21, 9:00 PM ET | Filing | |
| ROIV Roivant Sciences Ltd. | Sale | $24,160,402 | Sukhatme Mayukh President & CIO, Director | 664,826 sh | at $36.34 | Filed Aug 18, 9:00 PM ET | Filing | |
| ROIV Roivant Sciences Ltd. | Sale | $6,990,000 | Venker Eric President & Immunovant CEO | 200,000 sh | at $34.95 | Filed Jul 29, 9:00 PM ET | Filing |